Jyothy Labs share news, announcements and annual reports
NSE: JYOTHYLABBSE: 532926Household ProductsSmall Cap
Jyothy Labs Limited · Formerly Jyothy Laboratories · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2007
Last close ₹171.91down ₹3.15 (1.80%)BSE ₹172.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹175.06.
30 Oct: open ₹174.45, high ₹175.10, low ₹171.00
52-week range of traded prices to 30 Oct 2026
₹171.00Low, 30 Oct 2026₹322.75High, 30 Oct 2025
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and buyback. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,313 Cr603rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.23
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.04%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 19.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,85,76453.8% delivered
Jyothy Labs board meetings
112 filed, newest first. Page 3 of 3.
Jul 2010
20 Jul · Board meeting
Inter-alia to consider and take on record the Un-audited Financial Results of the Company for the 1st Quarter ended June 30, 2010.
Jun 2010
21 Jun · Board meeting
Board of Directors of the Company have on June 21, 2010 approved the following business through resolutions passed by circulation : (1) Issue of Equity Shares to Qualified Institutional Buyers (QIB's) through Qualified Institutional Placement (QIP) up to an amount of Rs. 300 Crore; (2) Constitution of Capital Issue Committee for the purpose of (1) above; (3) Amendment to the Notice and Explanatory Statement under Section 173(2) of the Companies Act, 1956, convening Annual General Meeting of the Company (AGM) by inclusion of the above item (1) for the purpose of obtaining approval of the members at the AGM.
May 2010
14 May · Board meeting
To consider inter alia the following: (1) Results of the Company for the Financial Year ended March 31, 2010. (2) Declaration of Dividend, if any, for the said Financial Year.
Jan 2010
11 Jan · Board meeting
Meeting on 27 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
14 Oct · Board meeting
Inter-alia to consider and take on record the Un-Audited Financial Results of the Company for the 2nd Quarter / Half Year ended September 30, 2009.
Jul 2009
16 Jul · Board meeting
Meeting on 30 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
May 2009
26 May · Board meeting
To consider inter-alia the following: (a) Results of the Company for the Financial Period ended March 31, 2009 (9 Months), & (b) Declaration of dividend, if any, for the said Financial Period.
Jan 2009
13 Jan · Board meeting
Meeting on 23 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
15 Oct · Board meeting
Meeting on 23 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Aug 2008
18 Aug · Board meeting
To consider inter-alia the following: (a) The Financial Results of the Company for the 4th Quarter/Year ended June 30, 2008 (Financial Year). (b) Declaration of dividend for the said Financial Year, and (c) Stock split of Equity Shares of the Company.
Apr 2008
11 Apr · Board meeting
Inter-alia to consider and take on record the Un-Audited Financial Results of the Company for the 3rd Quarter ended March 31, 2008.
Jan 2008
11 Jan · Board meeting
Inter-alia to consider and take on record the Un-audited Financial Results of the Company for the 2nd Quarter and for the Half Year ended December 31, 2007.